ACC.26 advanced registration ends Feb. 12 – register now!

Ziad Hijazi, MD, PhD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bristol-Myers Squibb, Boehringer-Ingelheim, Merck Sharp&Dohme, Pfizer, Roche Diagnostics(MODEST)

View Full Disclosure